Middle East & Africa ELISA Diagnostics Tests Market

Historic Data: 2020-2021   |   Base Year: 2022   |    Forecast Period: 2023-2030

Analysis - by Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), and End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others)


No. of Pages: 98  |  Report Code: BMIRE00029817  |  Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa ELISA Diagnostics Tests Market

The Middle East & Africa ELISA diagnostics tests market was valued at US$ 67.74 million in 2022 and is expected to reach US$ 94.26 million by 2030; it is estimated to grow at a CAGR of 4.2% from 2022 to 2030.



Advancements in ELISA-Based Procedures Boost Middle East & Africa ELISA Diagnostics Tests Market

The use of ELISA for in-vitro diagnostics (IVD) has gained considerable attention in the global market. Researchers from various fields have been attracted to the development and application of ELISA-based procedures through techniques such as magnetic beads, paper-based platforms, and nanomaterials. Other examples of technology-based ELISA kits are digital ELISA, Multiplex ELISA, Single-Molecule ELISA, Nanoparticle-Based ELISA, and Smartphone-Based ELISA. Also, companies launch ELISA testing kits based on several techniques for fast and efficient clinical results. The "AMP'D ELISA Signal Amplification system" is manufactured by Enzo Life Sciences, Inc. The AMP'D Technology efficiently improves the sensitivity of sandwich ELISA test type with a single amplification kit and offers high sensitivity.

Cell Signaling Technology, Inc.'s "PathScan Phospho-RSK1 (Ser380) Sandwich ELISA Kit," designed by Cell Signaling Technology, is another example of a technology-advanced ELISA test kit product. Such advanced technology-based ELISA test kit products will have a high demand in the future by veterinarian for the detection of different species responsible for veterinary and human-associated infections or diseases. Therefore, advancements in ELISA-based procedures are expected to bolster the ELISA diagnostic test market growth during 2020-2030. ELISA diagnostic test.

Middle East & Africa ELISA Diagnostics Tests Market Overview

There is a high prevalence of Tomato yellow leaf curl virus (TYLCV) belonging to the genus begomovirus of the family Geminiviridae. The TYLCV causes serious damage to tomato plants with up to 96.9% yield loss and quality reduction with transmission through whitefly and mechanically from infected tomatoes to different species such as Amarnthaceae, Chenopodiaceae, Cruciferae, Cucurbitaceae, Leguminaceae (Fabaceae), Malvaceae, and Solanaceae. To control the transmission of TYLCV to the Saudi population, the ELISA test is in high demand among the population and diagnostic laboratories.

Additionally, cases of hepatitis C virus (HCV) infection are rising among the Saudi population. The average prevalence rate of HBsAg is 7% in the Kingdom of Saudi Arabia (KSA). Therefore, the government adopted a policy to integrate hepatitis B vaccination and extend the program of immunization. Also, with the rising prevalence of HCV, diagnostic testing has increased by testing through the ELISA system. Therefore, rising HCV and TYLCV infection cases among the Saudi population propel the demand for ELISA systems.

Middle East & Africa ELISA Diagnostics Tests Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa ELISA Diagnostics Tests Market Segmentation

The Middle East & Africa ELISA diagnostics tests market is segmented based on adoption, test type, application, end user, and country. Based on adoption, the Middle East & Africa ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held a larger market share in 2022.

In terms of test type, the Middle East & Africa ELISA diagnostics tests market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held the largest market share in 2022.

Based on application, the Middle East & Africa ELISA diagnostics tests market is segmented into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held the largest market share in 2022.

By end user, the Middle East & Africa ELISA diagnostics tests market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held the largest market share in 2022.

Based on country, the Middle East & Africa ELISA diagnostics tests market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa ELISA diagnostics tests market share in 2022.

Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., DiaSorin SpA, and Elabscience Biotechnology Inc. are some of the leading companies operating in the Middle East & Africa ELISA diagnostics tests market.

Middle East & Africa ELISA Diagnostics Tests Strategic Insights

Strategic insights for the Middle East & Africa ELISA Diagnostics Tests provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/middle-east-and-africa-elisa-diagnostics-tests-market-strategic-framework.webp
Get more information on this report

Middle East & Africa ELISA Diagnostics Tests Report Scope

Report Attribute Details
Market size in 2022 US$ 67.74 Million
Market Size by 2030 US$ 94.26 Million
Global CAGR (2022 - 2030) 4.2%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Adoption
  • Human
  • Veterinary
By Test Type
  • Sandwich ELISA
  • Indirect ELISA
  • Competitive ELISA
  • Multiple & Portable ELISA
By Application
  • Autoimmune Diseases
  • Infectious Diseases
  • Cancer Diagnosis
  • Protein Quantification
By End User
  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Veterinary Hospitals & Diagnostic Laboratories
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Bio-Rad Laboratories Inc.
  • Idexx Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Danaher Corp.
  • DiaSorin SpA
  • Elabscience Biotechnology Inc.
Get more information on this report

Middle East & Africa ELISA Diagnostics Tests Regional Insights

The geographic scope of the Middle East & Africa ELISA Diagnostics Tests refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

geography/middle-east-and-africa-elisa-diagnostics-tests-market-geography.webp
Get more information on this report

The List of Companies - Middle East & Africa ELISA Diagnostics Tests Market

1. Bio-Rad Laboratories Inc.

2. Idexx Laboratories Inc.

3. F. Hoffmann-La Roche Ltd.

4. Thermo Fisher Scientific Inc.

5. Abbott Laboratories

6. Danaher Corp.

7. DiaSorin SpA

8. Elabscience Biotechnology Inc.

Frequently Asked Questions
How big is the Middle East & Africa ELISA Diagnostics Tests Market?

The Middle East & Africa ELISA Diagnostics Tests Market is valued at US$ 67.74 Million in 2022, it is projected to reach US$ 94.26 Million by 2030.

What is the CAGR for Middle East & Africa ELISA Diagnostics Tests Market by (2022 - 2030)?

As per our report Middle East & Africa ELISA Diagnostics Tests Market, the market size is valued at US$ 67.74 Million in 2022, projecting it to reach US$ 94.26 Million by 2030. This translates to a CAGR of approximately 4.2% during the forecast period.

What segments are covered in this report?

The Middle East & Africa ELISA Diagnostics Tests Market report typically cover these key segments-

  • Adoption (Human, Veterinary)
  • Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, Multiple & Portable ELISA)
  • Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification)
  • What is the historic period, base year, and forecast period taken for Middle East & Africa ELISA Diagnostics Tests Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa ELISA Diagnostics Tests Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Middle East & Africa ELISA Diagnostics Tests Market?

    The Middle East & Africa ELISA Diagnostics Tests Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Bio-Rad Laboratories Inc.
  • Idexx Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Danaher Corp.
  • DiaSorin SpA
  • Elabscience Biotechnology Inc.
  • Who should buy this report?

    The Middle East & Africa ELISA Diagnostics Tests Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa ELISA Diagnostics Tests Market value chain can benefit from the information contained in a comprehensive market report.